MEIP - MEI Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MEIP is currently covered by 2 analysts with an average price target of $25.55. This is a potential upside of $20.58 (414.08%) from yesterday's end of day stock price of $4.97.

MEI Pharma's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of MEIP is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 72 days.

Highest price target for MEIP is $6, Lowest price target is $3, average price target is $7.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 12-Apr-2024.

Currently out of the existing stock ratings of MEIP, 4 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$2.11 (43.15%)

$7

1 years 4 months 10 days ago
(12-Apr-2024)

0/4 (0%)

$3.73 (114.07%)

Sell

$2

$-0.69 (-25.65%)

$20

2 years 6 months 14 days ago
(08-Feb-2023)

0/3 (0%)

$-3.36 (-62.69%)

Buy

2 years 8 months 16 days ago
(06-Dec-2022)

2/2 (100%)

$-42.22 (-77.87%)

648

Buy

$6

3 years 2 months 16 days ago
(06-Jun-2022)

0/1 (0%)

$1.82 (43.54%)

Hold

$2

$-1.54 (-43.50%)

$80

3 years 4 months 28 days ago
(25-Mar-2022)

0/2 (0%)

$-7.8 (-79.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MEIP (MEI Pharma) average time for price targets to be met?

On average it took 72 days on average for the stock forecasts to be realized with a an average price target met ratio 11.11

Which analyst has the current highest performing score on MEIP (MEI Pharma) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the current lower performing score on MEIP (MEI Pharma) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on MEIP (MEI Pharma)?

Robyn Karnauskas works at TRUIST and has 7 price targets and 6 ratings on MEIP

Which analyst is the currently most bullish on MEIP (MEI Pharma)?

Thomas Shrader with highest potential upside - $172.99

Which analyst is the currently most reserved on MEIP (MEI Pharma)?

Jim Birchenough with lowest potential downside - -$1.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?